Similar articles for PMID: 26692119

Year	Number of Results
1946	1
1985	1
1999	2
2001	1
2002	1
2003	1
2004	3
2005	2
2006	2
2007	12
2008	4
2009	4
2010	7
2011	13
2012	13
2013	23
2014	24
2015	43
2016	47
2017	44
2018	42
2019	25
2020	22
2021	29
2022	30
2023	11
2024	0

1

Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.

Kimura K, Momose T, Hasegawa T, Morita T, Misawa T, Motoki H, Izawa A, Ikeda U. Kimura K, et al. J Cardiol. 2016 May;67(5):399-405. doi: 10.1016/j.jjcc.2015.09.020. Epub 2015 Dec 11. J Cardiol. 2016. PMID: 26692119 Free article. Clinical Trial.

2

Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.

Matsue Y, Suzuki M, Seya M, Iwatsuka R, Mizukami A, Nagahori W, Ohno M, Matsumura A, Hashimoto Y. Matsue Y, et al. J Cardiol. 2013 Feb;61(2):169-74. doi: 10.1016/j.jjcc.2012.08.020. Epub 2012 Nov 16. J Cardiol. 2013. PMID: 23159210 Free article.

3

Impact of Continuous Administration of Tolvaptan on Preventing Medium-Term Worsening Renal Function and Long-Term Adverse Events in Heart Failure Patients with Chronic Kidney Disease.

Nakano Y, Mizuno T, Niwa T, Mukai K, Wakabayashi H, Watanabe A, Ando H, Takashima H, Murotani K, Waseda K, Amano T. Nakano Y, et al. Int Heart J. 2018 Jan 27;59(1):105-111. doi: 10.1536/ihj.16-625. Epub 2018 Jan 15. Int Heart J. 2018. PMID: 29332911 Free article.

4

Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.

Matsue Y, Suzuki M, Nagahori W, Yoshida K, Onishi Y, Satoh Y, Ono Y, Nishioka T, Noda M, Sugi K, Torii S, Tejima T, Sakurada H, Yamaguchi S, Okishige K, Fujii H, Takahashi A. Matsue Y, et al. Cardiovasc Drugs Ther. 2014 Feb;28(1):73-7. doi: 10.1007/s10557-013-6491-8. Cardiovasc Drugs Ther. 2014. PMID: 24048511 Clinical Trial.

5

Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction　- Prospective Randomized Controlled Study.

Tamaki S, Sato Y, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Ozaki T, Seo M, Ikeda I, Fukuhara E, Abe M, Nakamura J, Fukunami M. Tamaki S, et al. Circ J. 2017 Apr 25;81(5):740-747. doi: 10.1253/circj.CJ-16-1122. Epub 2017 Feb 16. Circ J. 2017. PMID: 28202885 Free article. Clinical Trial.

6

Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure.

Kinoshita M, Okayama H, Kosaki T, Hosokawa S, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Hiasa G, Yamada T, Matsuoka H, Kazatani Y. Kinoshita M, et al. Heart Vessels. 2018 Feb;33(2):163-169. doi: 10.1007/s00380-017-1048-6. Epub 2017 Sep 9. Heart Vessels. 2018. PMID: 28889231

7

Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials.

Ma G, Ma X, Wang G, Teng W, Hui X. Ma G, et al. BMJ Open. 2019 May 1;9(4):e025537. doi: 10.1136/bmjopen-2018-025537. BMJ Open. 2019. PMID: 31048435 Free PMC article.

8

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure.

Niikura H, Iijima R, Anzai H, Kogame N, Fukui R, Takenaka H, Kobayashi N. Niikura H, et al. Anatol J Cardiol. 2017 Sep;18(3):206-212. doi: 10.14744/AnatolJCardiol.2017.7628. Epub 2017 Aug 2. Anatol J Cardiol. 2017. PMID: 28777097 Free PMC article. Clinical Trial.

9

Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.

Uemura Y, Shibata R, Takemoto K, Uchikawa T, Koyasu M, Ishikawa S, Mitsuda T, Miura A, Imai R, Iwamiya S, Ozaki Y, Kato T, Miura T, Watarai M, Murohara T. Uemura Y, et al. Heart Vessels. 2016 Oct;31(10):1643-9. doi: 10.1007/s00380-015-0775-9. Epub 2015 Nov 28. Heart Vessels. 2016. PMID: 26615607

10

The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.

Matsumoto K, Ehara S, Nakamura Y, Otsuka K, Kawase Y. Matsumoto K, et al. Heart Vessels. 2018 Oct;33(10):1204-1213. doi: 10.1007/s00380-018-1177-6. Epub 2018 Apr 23. Heart Vessels. 2018. PMID: 29687159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

343 results

Results by year